Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisabetta Bugianesi"'
Autor:
Angelo Armandi, Giorgia Colombo, Chiara Rosso, Gian Paolo Caviglia, Antonella Olivero, Maria Lorena Abate, Marta Guariglia, Nuria Perez Diaz del Campo, Gabriele Castelnuovo, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Armando A. Genazzani, Elisabetta Bugianesi
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1172 (2023)
Intrahepatic oxidative stress is a key driver of inflammation and fibrogenesis in non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the role of extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) and extracellular nicotinic
Externí odkaz:
https://doaj.org/article/cf33fb1764514653b895b8ee42a4530c
Autor:
Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Melania Gaggini, Fabrizia Carli, Maria Lorena Abate, Antonella Olivero, Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Amalia Gastaldelli, Elisabetta Bugianesi
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 22, p 8838 (2020)
Background: Pathogenetic mechanisms involved in the progression of non-alcoholic fatty liver disease (NAFLD) are complex and multifactorial. We investigated oxidative stress through the measurement of selenoprotein P (SeP) in serum and we explored it
Externí odkaz:
https://doaj.org/article/f93326a2054a488dbd1b9c125b456635
Autor:
Salvatore Petta, Amalia Gastaldelli, Eleni Rebelos, Elisabetta Bugianesi, Piergiorgio Messa, Luca Miele, Gianluca Svegliati-Baroni, Luca Valenti, Ferruccio Bonino
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 12, p 2082 (2016)
The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style and inflammation, which have a major impact on the severity of the clinicopathologic outcome of non-alcoholic fatty liver disease. A short comprehensive revi
Externí odkaz:
https://doaj.org/article/be5c2395df674cb1bd3e0deb46392812
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 5, p 717 (2016)
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease but the second cause of death among NAFLD patients are attributed to malignancies at both gastrointestinal (liver, colon, esophagus, stomach, and pancreas) and extr
Externí odkaz:
https://doaj.org/article/b14b74aee8924d6e91fa0a2a3a8734cd
Autor:
Roberto Gambino, Elisabetta Bugianesi, Chiara Rosso, Lavinia Mezzabotta, Silvia Pinach, Natalina Alemanno, Francesca Saba, Maurizio Cassader
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 4, p 479 (2016)
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and nonalcoholic fatty liver disease (NAFLD). This work studied the increase in total FFA shown in NAFLD subjects to possibly characterize which fatty ac
Externí odkaz:
https://doaj.org/article/61d6bc5167264ac580b065e2e4560b5f
Autor:
Chiara Rosso, Lavinia Mezzabotta, Silvia Pinach, Roberto Gambino, Natalina Alemanno, Maurizio Cassader, Elisabetta Bugianesi, Francesca Saba
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 17, Iss 4, p 479 (2016)
International Journal of Molecular Sciences; Volume 17; Issue 4; Pages: 479
International Journal of Molecular Sciences, Vol 17, Iss 4, p 479 (2016)
International Journal of Molecular Sciences; Volume 17; Issue 4; Pages: 479
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and nonalcoholic fatty liver disease (NAFLD). This work studied the increase in total FFA shown in NAFLD subjects to possibly characterize which fatty ac